T.A. White v. PA DOC

CourtCommonwealth Court of Pennsylvania
DecidedMarch 6, 2025
Docket508 M.D. 2023
StatusUnpublished

This text of T.A. White v. PA DOC (T.A. White v. PA DOC) is published on Counsel Stack Legal Research, covering Commonwealth Court of Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
T.A. White v. PA DOC, (Pa. Ct. App. 2025).

Opinion

IN THE COMMONWEALTH COURT OF PENNSYLVANIA

Travis A. White, : Petitioner : : v. : No. 508 M.D. 2023 : SUBMITTED: November 7, 2024 PA DOC, SCI Houtzdale Warden : Scott Klinefelter, Medical Director, : MAT Specialist, Dr. Naji, Dr. Bloom, : and Dr. Knowles, : Respondents :

BEFORE: HONORABLE RENÉE COHN JUBELIRER, President Judge HONORABLE LORI A. DUMAS, Judge HONORABLE BONNIE BRIGANCE LEADBETTER, Senior Judge

OPINION NOT REPORTED

MEMORANDUM OPINION BY SENIOR JUDGE LEADBETTER FILED: March 6, 2025

Petitioner Travis A. White, pro se, is an inmate at the State Correctional Institution – Houtzdale (SCI-Houtzdale) who has filed a petition for review under the Americans with Disabilities Act1 (ADA) and the Eighth and Fourteenth Amendments to the United States Constitution2 by way of Section 1983 of the United

1 42 U.S.C. §§ 12101-12213.

2 U.S. CONST. amends. VIII, XIV. States Code, 42 U.S.C. § 1983.3 Petitioner seeks injunctive relief4 against Respondent “PA DOC” (the Pennsylvania Department of Corrections) “so [the Department] will give [him] [Medically Assisted Treatment (MAT) program] medication that [his] body can tolerate”—specifically one not containing naltrexone, such as Suboxone, Subutex, or methadone—for his opiate use disorder.5 Pet. for Review, “P.F.R.” ¶ 20. Now before us are the preliminary objections of Respondents Department and personnel of SCI-Houtzdale, Warden Scott Klinefelter (Superintendent Klinefelter6), and the person identified as “MAT Specialist” (collectively, Department Respondents), and Dr. Naji, the Medical Director at SCI- Houtzdale7 to the petition for review.

3 See Pet. for Review “P.F.R.” ¶ 2. Petitioner’s petition for review does not allege discrete causes of action in separate counts, as required by Pennsylvania Rule of Civil Procedure 1020(a), Pa.R.Civ.P. 1020(a). However, Respondents have not preliminarily objected to any failure to conform to rule of court.

4 Petitioner does not, per se, ask for a permanent injunction in his petition for review but asserts that he seeks both a preliminary and permanent injunction elsewhere, see Petitioner’s Response to Department Respondents’ Preliminary Objections ¶ 18. This issue is discussed further, infra.

5 In addition to the medications requested by Petitioner, MAT includes administration of medications containing naltrexone. See Rokita v. Pa. Dep’t of Corr., 273 A.3d 1260, 1263 (Pa. Cmwlth. 2022) (en banc) [petitioner seeking Vivitrol (naltrexone) through MAT program].

6 Department Respondents’ brief refers to Klinefelter as superintendent rather than warden.

7 The petition for review in this matter names “Medical Director” and Dr. Naji as Respondents. Dr. Naji identifies himself as medical director for SCI-Houtzdale, as a contracted medical provider for the Department employed by Wellpath, LLC, a private company. Dr. Naji’s Prelim. Objs. ¶ 18.

(Footnote continued on next page…)

2 The facts alleged by Petitioner may be summarized as follows.8 Petitioner is an inmate at SCI-Houtzdale who wishes to be given MAT medications for opiate use disorder, from which he suffers. P.F.R. ¶¶ 1-2, 7. Petitioner “run[s] the risk of death due to cravings and tolerance being so low if relapse occurs”; his addiction causes him depression; and he has attempted suicide. P.F.R. ¶ 3. The opiate use disorder medications that have been offered to him—Vivitrol or Revia9— contain naltrexone, which causes him “major depression” and suicidal thoughts.

In addition to the preliminary objections before us, the remaining captioned respondents were dismissed on preliminary objections sustained for failure to properly serve the petition for review. White v. Pa. Dep’t of Corr. (Pa. Cmwlth., No. 508 M.D. 2023, Order filed Aug. 14, 2024) [dismissing Dr. Bloom and Joyce Knowles, CRNP (incorrectly identified in caption as Dr. Knowles)].

8 We note that

[i]n ruling on preliminary objections, this Court accepts as true all well-pled allegations of material fact, as well as all inferences reasonably deducible from those facts. Key v. Pa. Dep’t of Corr., 185 A.3d 421 (Pa. Cmwlth. 2018). However, this Court need not accept unwarranted inferences, conclusions of law, argumentative allegations, or expressions of opinion. Id. For preliminary objections to be sustained, it must appear with certainty that the law will permit no recovery. Id. Any doubt must be resolved in favor of the non-moving party. Id.

Feliciano v. Pa. Dep’t of Corr., 250 A.3d 1269, 1274 (Pa. Cmwlth. 2021) (en banc) [quoting Dantzler v. Wetzel, 218 A.3d 519, 522 n.3 (Pa. Cmwlth. 2019)].

9 In the course of his petition for review, Petitioner names several drugs used to treat opiate use disorder. Petitioner avers that “many doctors will tell the Court that Suboxone, Subutex, and methadone are the gold standard for treating opiate use disorder.” P.F.R. ¶ 20. The Court takes judicial notice that Subutex and Suboxone are brand names for medications which each contain buprenorphine hydrochloride and that Vivitrol and Revia, as Petitioner states, contain naltrexone. See Drugs@FDA: FDA Approved Drugs, https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm (last visited Mar. 5, 2025).

3 P.F.R. ¶ 4. Petitioner was in a methadone10 maintenance program within 60 days before entering prison and provided records indicating that to the Department; and Petitioner avers that this record would be sufficient for other inmates to get Subutex or Sublocade.11 P.F.R. ¶ 5. Petitioner suffers from several physical ailments which the Department has not treated, and MAT would help the pain from those conditions. P.F.R. ¶ 7. Petitioner denies that he currently uses drugs, but sometimes relapses because of lack of treatment and uncontrollable urges to use opiates, which MAT would treat. P.F.R. ¶ 16. Petitioner avers that the medical professionals at SCI- Houtzdale, including the MAT Specialist, Dr. Naji, and the now-dismissed named respondents “agree that [he] need[s] MAT” (in the form he is seeking), but that it was denied due to Department policy or policies which allow others to use the medications, but prevent him from using a MAT medication other than Vivitrol or Revia for his opiate use disorder. P.F.R. ¶¶ 6, 19. Those policies, Petitioner avers, do not permit the Department to give methadone to male inmates or the Subutex or Sublocade because he “came before 2019.” P.F.R. ¶ 6. Petitioner exhausted his administrative remedies and filed the instant petition for review in our original jurisdiction. Department Respondents have filed preliminary objections, as has Dr. Naji. Petitioner has filed responses thereto. The preliminary objections are now ripe for disposition. The Department Respondents raise two issues on preliminary objections: (1) whether the Court has jurisdiction over Superintendent Klinefelter

10 Petitioner avers that the Department does not give methadone to male inmates. P.F.R. ¶ 5.

11 Sublocade is another treatment for opiate use disorder that contains buprenorphine. See Drugs@FDA: FDA Approved Drugs, https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm (last visited Mar. 5, 2025).

4 and the MAT Specialist as non-statewide actors; and (2) whether Petitioner has failed to state a claim against Department Respondents for which relief can be granted (demurrer). Dr. Naji raises three issues on preliminary objections: (1) whether the Court has jurisdiction over Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Robinson v. California
370 U.S. 660 (Supreme Court, 1962)
Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
County of Sacramento v. Lewis
523 U.S. 833 (Supreme Court, 1998)
Alsbrook v. City Of Maumelle
184 F.3d 999 (Eighth Circuit, 1999)
Farmer v. Brennan
511 U.S. 825 (Supreme Court, 1994)
Commonwealth v. Coward
414 A.2d 91 (Supreme Court of Pennsylvania, 1980)
Danysh v. Department of Corrections
845 A.2d 260 (Commonwealth Court of Pennsylvania, 2004)
Mickens v. JEFFES
453 A.2d 1092 (Commonwealth Court of Pennsylvania, 1983)
Summit Towne Centre, Inc. v. Shoe Show of Rocky Mount, Inc.
828 A.2d 995 (Supreme Court of Pennsylvania, 2003)
Kretchmar v. Commonwealth, Department of Corrections
831 A.2d 793 (Commonwealth Court of Pennsylvania, 2003)
BIG BASS LAKE COMMUNITY ASS'N v. Warren
950 A.2d 1137 (Commonwealth Court of Pennsylvania, 2008)
Pennsylvania Public Utility Commission v. Israel
52 A.2d 317 (Supreme Court of Pennsylvania, 1947)
Skytop Meadow Community Association, Inc. v. C. Paige and M.A. Paige
177 A.3d 377 (Commonwealth Court of Pennsylvania, 2017)
Key v. Pa. Dep't of Corr.
185 A.3d 421 (Commonwealth Court of Pennsylvania, 2018)
Jones v. Peterman
743 A.2d 537 (Commonwealth Court of Pennsylvania, 1999)
Commonwealth v. Blakeney
108 A.3d 739 (Supreme Court of Pennsylvania, 2014)
Alexander v. Weiner
841 F. Supp. 2d 486 (D. Massachusetts, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
T.A. White v. PA DOC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ta-white-v-pa-doc-pacommwct-2025.